ABSTRACT
INTRODUCTION: Radiolabelled autologous white blood cells (WBC) scintigraphy is being standardized all over the world to ensure high quality, specificity and reproducibility. Similarly, in many European countries radiolabelled anti-granulocyte antibodies (anti-G-mAb) are used instead of WBC with high diagnostic accuracy. The EANM Inflammation & Infection Committee is deeply involved in this process of standardization as a primary goal of the group. AIM: The main aim of this guideline is to support and promote good clinical practice despite the complex environment of a national health care system with its ethical, economic and legal aspects that must also be taken into consideration. METHOD: After the standardization of the WBC labelling procedure (already published), a group of experts from the EANM Infection & Inflammation Committee developed and validated these guidelines based on published evidences. RESULTS: Here we describe image acquisition protocols, image display procedures and image analyses as well as image interpretation criteria for the use of radiolabelled WBC and monoclonal antigranulocyte antibodies. Clinical application for WBC and anti-G-mAb scintigraphy is also described. CONCLUSIONS: These guidelines should be applied by all nuclear medicine centers in favor of a highly reproducible standardized practice.
Subject(s)
Antibodies, Monoclonal/immunology , Granulocytes/immunology , Image Processing, Computer-Assisted , Leukocytes/metabolism , Nuclear Medicine , Practice Guidelines as Topic , Societies, Medical , Antibodies, Monoclonal/metabolism , Humans , Radionuclide ImagingABSTRACT
Non-ossifying fibromas (NOF) are a benign entity of the developing bone, relatively common in children and young adults. Their location is most frequently metaphyseal. They are usually asymptomatic (unless associated to a fracture) and have a self-limited behavior, with spontaneous regression through a sclerotic consolidation. Plain X-ray is the main imaging tool for its diagnosis. However, an unclear X-ray may lead to further imaging studies. We present the case of a 17-year-old male with back pain and lower limb dysmetria referred for a bone scintigraphy to complete the diagnostic and assess disease extension and the subsequent MRI evaluation.
Subject(s)
Bone Neoplasms/diagnostic imaging , Fibroma/diagnostic imaging , Neoplasms, Multiple Primary/diagnostic imaging , Single Photon Emission Computed Tomography Computed Tomography , Tibia/diagnostic imaging , Adolescent , Humans , Magnetic Resonance Imaging , MaleABSTRACT
This paper presents the different views of the gastroenterologist, the radiologist and the nuclear medicine specialist in the management of inflammatory bowel disease. The role of clinical parameters and biochemical marker as well as the progressive use of the different imaging modalities: magnetic resonance, computerized tomography and nuclear medicine techniques is presented. The paper is an effort to combine the published European Crohn's and Colitis Organization, European Society of Gastrointestinal and Abdominal Radiology and European Association of Nuclear Medicine consensus with the conclusions of the multidisciplinary meeting organized in 2012 Milano during the EANM Congress with the objective of find a common diagnostic flowchart.
Subject(s)
Decision Support Systems, Clinical , Inflammatory Bowel Diseases/diagnostic imaging , Inflammatory Bowel Diseases/therapy , Congresses as Topic , Europe , Fluorodeoxyglucose F18 , Humans , Inflammatory Bowel Diseases/diagnosis , Leukocytes/cytology , Magnetic Resonance Imaging/methods , Nuclear Medicine/methods , Positron-Emission Tomography/methods , Radiopharmaceuticals , Technetium Tc 99m Exametazime , Tomography, Emission-Computed, Single-Photon/methods , Tomography, X-Ray Computed/methodsABSTRACT
The management of patients with IBD requires evaluation with objective tools, both at the time of diagnosis and throughout the course of the disease, to determine the location, extension, activity and severity of inflammatory lesions, as well as, the potential existence of complications. Whereas endoscopy is a well-established and uniformly performed diagnostic examination, the implementation of radiologic techniques for assessment of IBD is still heterogeneous; variations in technical aspects and the degrees of experience and preferences exist across countries in Europe. ECCO and ESGAR scientific societies jointly elaborated a consensus to establish standards for imaging in IBD using magnetic resonance imaging, computed tomography, ultrasonography, and including also other radiologic procedures such as conventional radiology or nuclear medicine examinations for different clinical situations that include general principles, upper GI tract, colon and rectum, perineum, liver and biliary tract, emergency situation, and the postoperative setting. The statements and general recommendations of this consensus are based on the highest level of evidence available, but significant gaps remain in certain areas such as the comparison of diagnostic accuracy between different techniques, the value for therapeutic monitoring, and the prognostic implications of particular findings.
Subject(s)
Diagnostic Imaging/standards , Evidence-Based Medicine , Inflammatory Bowel Diseases/diagnosis , Consensus , Europe , Humans , Inflammatory Bowel Diseases/pathologyABSTRACT
Craniopharyngioma is a histologically benign and frequently cystic intracranial tumor. It may present aggressive behavior due to compression from nearby structures. Its therapeutic management is complicated because although surgery is the usual treatment of choice, it is not exempt of high morbidity and mortality and frequent tumor recurrence. In craniopharyngiomas with a significant cystic component,internal irradiation with radioactive isotopes is a therapeutic alternative to conventional treatments. We present the cases of four patients with cystic craniopharyngiomas who were treated with intracystic administration of 90Y-colloid, and their evolution after the treatment.
Subject(s)
Craniopharyngioma/radiotherapy , Cysts/radiotherapy , Pituitary Neoplasms/radiotherapy , Radiopharmaceuticals/therapeutic use , Yttrium Radioisotopes/therapeutic use , Adult , Colloids/administration & dosage , Combined Modality Therapy , Craniopharyngioma/complications , Craniopharyngioma/surgery , Craniotomy , Diplopia/etiology , Female , Humans , Hypopituitarism/etiology , Injections, Intralesional , Male , Middle Aged , Paresis/etiology , Pituitary Neoplasms/complications , Pituitary Neoplasms/surgery , Radiopharmaceuticals/administration & dosage , Remission Induction , Vision Disorders/etiology , Young Adult , Yttrium Radioisotopes/administration & dosageABSTRACT
OBJECTIVE: To assess the role of FDG-PET/CT performed after the first cycles of chemotherapy in the prediction of response to treatment in patients with diffuse large B-cell lymphoma. METHODS: Twenty patients (mean age: 48 years) were included, 16 initial staging and 4 relapse. All patients underwent PET/CT at 3 times: 1) Baseline, 2) After 1-3 cycles of chemotherapy (early response assessment), and 3) End of treatment (evaluation of final response). Early PET/CT findings were correlated to the end-treatment PET/CT and follow-up. The evaluation of the response was established according to the decrease in uptake of the lesions (SUVmax). In the early assessment, a good response indicator (GRI) was obtained when the lesion disappeared or had more than 50% reduction in SUVmax. At the end of the treatment, a complete metabolic response (CMR) was determined in negative PET scans. Follow-up was superior to 19 months and final outcome was established as progression/relapse or no evidence of disease (NED). RESULTS: At the early treatment evaluation, 16/16 patients of initial staging (100%) and 2/4 of relapse (50%) achieved GRI. At the end of treatment evaluation, 14/16 patients of initial staging with GRI achieved CMR and 1/16 PMR: 14 were alive with NED in the follow-up while 1 relapsed. In the second group, 2/2 patients with GRI achieved CMR (100%): 1 continued with NED in the follow-up and another relapsed. CONCLUSION: FDG-PET/CT after the first cycles of chemotherapy is useful to monitor treatment due to its high negative predictive value (87.5%), using it to modify treatment early in the non-responders.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Multimodal Imaging , Positron-Emission Tomography , Tomography, X-Ray Computed , Adolescent , Adult , Aged , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Cisplatin/administration & dosage , Cyclophosphamide/administration & dosage , Cytarabine/administration & dosage , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Doxorubicin/administration & dosage , Etoposide/administration & dosage , Female , Fluorine Radioisotopes/pharmacokinetics , Fluorodeoxyglucose F18/pharmacokinetics , Humans , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Methylprednisolone/administration & dosage , Middle Aged , Neoplasm Staging , Organoplatinum Compounds/administration & dosage , Pilot Projects , Prednisone/administration & dosage , Radiopharmaceuticals/pharmacokinetics , Remission Induction , Rituximab , Tissue Distribution , Treatment Outcome , Vincristine/administration & dosage , Young AdultABSTRACT
AIM: To evaluate the usefulness of the (75)SeHCAT abdominal retention (AR) measurement in the early diagnosis of diarrhea syndrome (DS). METHODS: Thirty-seven patients with diarrhea syndrome within the first month of evolution were prospectively evaluated. The (75)Se-SeHCAT abdominal retention was measured 4 and 7 days post-administration of 0.01 mCi of (75)SeHCAT. The test was performed prior to treatment and at 3 months when the baseline study was positive. The test was considered positive if the RA was <25% at 4(th) and <10% on the 7th day. The patients were visited at 3 months. Depending on the response, 3 groups were established: a) complete response: normalization of stool frequency, b) partial response, decrease of frequency or c) no response. RESULTS: Group A: The AR of (75)Se-SEHCAT was normal in 21 patients. Six were diagnosed of colonic diverticulosis, 8 of irritable bowel syndrome, 1 of lymphocytic colitis, 1 of post-gastroenteritis syndrome, 1 of celiac disease and 1 of stenosis of the cardia. Four are still under study. Group B: The AR of (75)Se-SEHCAT decreased in 16 patients. All showed abnormal AR at day 7 and all but 1 at day 4. Following administration of cholestyramine resin, 8 (50%) presented partial response and 8 (50%) complete response. At 3 months, AR had increased at day 4 and 9 at day 7. CONCLUSION: The measurement of (75)SEHCAT abdominal retention allows the early diagnosis of bile acid malabsorption in 43% of the patients with DS. Measurement at 7 days seems more accurate than that at 4 days.
Subject(s)
Diarrhea/diagnostic imaging , Malabsorption Syndromes/diagnostic imaging , Radiopharmaceuticals , Selenium Radioisotopes , Taurocholic Acid/analogs & derivatives , Abdomen/diagnostic imaging , Adult , Aged , Aged, 80 and over , Anticholesteremic Agents/therapeutic use , Cardia/pathology , Celiac Disease/complications , Celiac Disease/diagnosis , Cholestyramine Resin/therapeutic use , Chronic Disease , Colitis, Lymphocytic/complications , Colitis, Lymphocytic/diagnosis , Constriction, Pathologic , Diarrhea/diagnosis , Diarrhea/drug therapy , Diarrhea/etiology , Diarrhea/metabolism , Diverticulosis, Colonic/complications , Diverticulosis, Colonic/diagnosis , Early Diagnosis , Female , Humans , Intestinal Absorption , Irritable Bowel Syndrome/complications , Irritable Bowel Syndrome/diagnosis , Malabsorption Syndromes/etiology , Male , Middle Aged , Prospective Studies , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Selenium Radioisotopes/pharmacokinetics , Taurocholic Acid/pharmacokinetics , Tissue DistributionSubject(s)
3-Iodobenzylguanidine , Benzamides , Dopamine/metabolism , Iodine Radioisotopes , Norepinephrine/metabolism , Nortropanes , Nuclear Medicine/statistics & numerical data , Pyrrolidines , Radiopharmaceuticals , Tomography, Emission-Computed, Single-Photon/statistics & numerical data , Central Nervous System Diseases/diagnostic imaging , France , Health Care Surveys , Humans , Parkinsonian Disorders/diagnostic imaging , Radiopharmaceuticals/classification , SpainABSTRACT
OBJECTIVE: The influence of the relationship between pre- and post-menopausal stage of patients with breast cancer (BC) and the risk of sentinel lymph node (SLN) metastasis as well as the influence of oestrogen receptor (ER) status within each one of these groups were analyzed. METHODS: A BC database with 1,388 patients was analysed. Three age groups were studied: A, elderly postmenopausal, 200 patients, ≥ 70 years old; B, younger postmenopausal, 89 patients, 55-69 years old; C, premenopausal, 85 patients, <55 years old. In each group 2 subgroups were analyzed: positive ER and negative ER tumours. Data analysed: SLN-positive patients, non-sentinel node (NSN)-positive patients, non-surgical detections (NSD) and non disease-free (NDF) patients after a follow-up of 52 months. STATISTICAL ANALYSIS: chi-squared test, significance: P ≤ 0.05. RESULTS: SLN metastasis was significantly (P<0.025) more common in premenopausal than in postmenopausal patients, and within those, mainly in negative ER tumours. Positive-NSN increases slightly in premenopausal patients (exclusively in negative ER tumours). NDF patients are similar in the 3 groups and in all of them it is much more frequent in negative ER tumours. CONCLUSION: SLN metastasis varies significantly according to hormonal state and not according to age, being more frequent in premenopausal patients and mainly in ER negative tumours.
Subject(s)
Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/secondary , Estrogens , Lymphatic Metastasis , Neoplasm Proteins/analysis , Neoplasms, Hormone-Dependent/pathology , Receptors, Estrogen/analysis , Sentinel Lymph Node Biopsy , Aged , Aged, 80 and over , Breast Neoplasms/chemistry , Breast Neoplasms/epidemiology , Carcinoma, Ductal, Breast/chemistry , Carcinoma, Ductal, Breast/epidemiology , Carcinoma, Ductal, Breast/pathology , Female , Humans , Middle Aged , Neoplasms, Hormone-Dependent/chemistry , Neoplasms, Hormone-Dependent/epidemiology , Postmenopause , Premenopause , Prevalence , Retrospective Studies , RiskABSTRACT
OBJECTIVE: To analyze the presence of anxiety in patients referred to a Nuclear Medicine Department (NMD). MATERIAL AND METHODS: A total of 148 patients were included: 67 were referred for radioiodine therapy, 48 with hyperthyroidism (HT), 19 with differentiated thyroid carcinoma (DTC), and 81 were referred for detection and biopsy of the sentinel node in breast cancer (BC). The following documents were filled out: personal data, a state-trait anxiety inventory, a scale of pre-disposing factors causing anxiety and an information questionnaire. Anxiety-predisposing factors and the influence of the information on the presence of anxiety were studied. RESULTS: HT patients: 47% had anxiety in the moment of the visit that was not related to the level of information received. The factor that worried them the most was the radioiodine administration. Being the first visit to a NMD significantly influenced (p<0.05) on the presence of anxiety. DTC patients: 42% had anxiety in the moment of the visit not related to the level of information received. The factor that worried them the most was the illness itself. No factor had a significant influence on the presence of anxiety. BC patients: 53% had anxiety in the moment of the visit that was not related to the level of information received. What worried them the most were the results. Having anxiety and/or depression significantly influenced (p<0.05) the presence of anxiety. CONCLUSION: The quantity of information given before a procedure in a NMD does not influence on the presence of anxiety. Nevertheless, it is our duty to give the best possible information.
Subject(s)
Anxiety/etiology , Breast Neoplasms/psychology , Carcinoma/psychology , Hyperthyroidism/psychology , Iodine Radioisotopes/therapeutic use , Radionuclide Imaging/psychology , Radiotherapy/psychology , Sentinel Lymph Node Biopsy/psychology , Thyroid Neoplasms/psychology , Adolescent , Adult , Aged , Anxiety/diagnosis , Carcinoma/radiotherapy , Depression/complications , Female , Humans , Hyperthyroidism/radiotherapy , Male , Middle Aged , Nuclear Medicine Department, Hospital , Patient Education as Topic , Radiation Injuries/psychology , Self-Assessment , Severity of Illness Index , Socioeconomic Factors , Surveys and Questionnaires , Thyroid Neoplasms/radiotherapy , Young AdultABSTRACT
UNLABELLED: The efficacy of carotid endartectomy (CE) in cerebrovascular accidents produced by carotid stenosis can be evaluated with the cerebral perfusion with single photon emission tomography, using statistical parametric mapping (SPM). MATERIAL AND METHODS: Twelve patients with significant carotid stenosis who underwent endartectomy were included in the study. All underwent a cerebral perfusion study with 99mTc-etilen cisteinato dietilester (ECD) at baseline and after the endartectomy. Using SPM, the baseline/post-surgery study was compared independently with the control group made up of 20 patients and the corresponding parametric statistical mappings were obtained. Changes in extension (k(E) or voxel number) and intensity (change in the T value) of the significantly hypoperfused zones and direction of these changes were evaluated. RESULTS: In the group of 12 patients, improvement of the post-surgical cerebral perfusion was observed in 5 patients with an average 50.56% decrease in the extension of the hypoperfused zones and average 30.9% decrease of intensity. Four patients showed an average 85.53% increase in the extension of cerebral hypoperfusion and of 34.21% in intensity. No significant changes between both studies were found in three patients. CONCLUSIONS: SPM has been shown to be a useful tool that makes it possible to objectify the cerebral brain flow changes produced after the surgical intervention, evaluating the changes in extension and intensity of the significantly hypoperfused zones.
Subject(s)
Brain Ischemia/diagnostic imaging , Brain/diagnostic imaging , Carotid Stenosis/surgery , Cerebrovascular Circulation , Endarterectomy, Carotid , Postoperative Complications/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Aged , Aged, 80 and over , Brain/blood supply , Brain Ischemia/etiology , Carotid Stenosis/complications , Carotid Stenosis/physiopathology , Female , Humans , Male , Middle Aged , Models, Statistical , Organotechnetium Compounds , Postoperative Complications/etiology , RadiopharmaceuticalsABSTRACT
AIM: To determine whether preoperative factors, such as size of metastases in the sentinel lymph node (SLN), number of positive SLNs (1, >1), tumoral grade, lymphovascular invasion (LVI) and tumoral size can predict the presence of metastases in non-SLNs, when the SLN is positive. METHODS: The study population was 1 146 breast cancer patients. Lymphadenectomy was performed in 150. Three groups of patients were established depending on the size of the metastases in SLNs: group A: <2 mm; group B: 2 < or =GC < or =5 mm; group C: > 5 mm. Either the chi(2) test or Fisher's test was performed to compare categorical variables, and a multivariate conditional logistic regression model for data sets was performed to identify the deterministic factors of metastases presence. RESULTS: Ten percent of group A, 28% of group B and 52% of group C presented non-SLN metastases. Patients with >1 positive-SLN presented significantly more non-SLN metastases than those with only one positive-SLN; 56% of patients with LVI presented non-SLN metastases versus 26% of those without LVI. The tumoral grade and size did not seem to have any influence on the number of patients with non-SLN metastases. The number of positive-SLNs and size of metastases were statistically associated with the presence of metastases. CONCLUSIONS: In this study population, the probability of finding non-SLN metastases was statistically related to the size of the SLN metastases and the number of positive-SLNs.
Subject(s)
Breast Neoplasms/diagnosis , Lymph Nodes/diagnostic imaging , Lymph Nodes/pathology , Positron-Emission Tomography/statistics & numerical data , Adult , Aged , Aged, 80 and over , Axilla , Breast Neoplasms/epidemiology , Breast Neoplasms/surgery , Humans , Incidence , Lymphatic Metastasis , Mastectomy , Middle Aged , Preoperative Care/statistics & numerical data , Prognosis , Reproducibility of Results , Risk Assessment/methods , Risk Factors , Sensitivity and Specificity , Sentinel Lymph Node Biopsy , Spain/epidemiologyABSTRACT
AIM: The aim of this study was to analyse the relationship between left ventricular ejection fractions (EF) obtained using four different instruments. MATERIAL AND METHODS: Eighty-five EF values were analysed. Gated acquisition was performed with the same gammacamera (SOPHA) using 99mTc-labelled red cells. Each EF was obtained using four processing systems: NXT (SOPHA), Entegra (Gems), Odyssey (Philips) and Esoft (Siemens), always working in automated mode. The paired student's t-test, Spearman correlation and Bland-Altman analysis were used to compare methods, and Deming regression was applied. RESULTS: Mean values and standard deviations for each program were: NXT: 61 +/- 9; Entegra: 60 +/- 10; Odyssey: 60 +/- 9; Esoft: 60 +/- 10. Although no significant differences were found as a whole and the values were linearly related, the methods are not interchangeable. CONCLUSIONS: The same program should be used in the follow-up of each patient, which is now easily achievable by means of the DICOM standard.
Subject(s)
Gated Blood-Pool Imaging/instrumentation , Stroke Volume , Electrocardiography , Erythrocytes , Gated Blood-Pool Imaging/methods , Humans , Radiopharmaceuticals , Reproducibility of Results , Software , TechnetiumSubject(s)
Carcinoma, Renal Cell/diagnosis , Carcinoma, Renal Cell/secondary , Kidney Neoplasms/diagnostic imaging , Muscle Neoplasms/diagnosis , Muscle Neoplasms/secondary , Neoplasms, Unknown Primary/diagnostic imaging , Adult , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/pathology , Diagnosis, Differential , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Lymphatic Metastasis , Magnetic Resonance Imaging , Male , Muscle Neoplasms/diagnostic imaging , Muscle Neoplasms/pathology , Radiography , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/secondary , Thigh , Thrombophlebitis/diagnostic imaging , UltrasonographyABSTRACT
OBJECTIVE: We have compared the uncorrected images of SPECT myocardial perfusion plus gated data with corrected images with X-rays in the management of coronary artery disease. METHODS: In 60 patients (p) a stress/rest-gated myocardial perfusion SPECT was performed with attenuation correction with a hybrid gammacamera. All patients underwent cardiac catheterization. 3 types of images were qualitatively evaluated: uncorrected stress/rest (NC), uncorrected stress/rest plus gated (NCG) and stress/rest corrected for attenuation with scatter correction (AC). McNemar's test was used to analyze the statistical differences in assessing the diagnostic accuracy of each type of images; p < 0.05 was considered statistically significant. RESULTS: Fourteen p did not have significant lesions in the coronary arteries (NSL), 46 p showed lesions in coronary arteries: 29 in anterior descending, 26 in right coronary and 18 in circumflex. In right coronary territory, diagnostic accuracy was significantly higher on AC than on NC images (p < 0.001) and on AC than on NCG images (p < 0.01). In NSL group there are significant differences between NC and AC (p < 0.02) and between NCG and AC (p < 0.05). CONCLUSIONS: Attenuation correction with X-rays significantly improves diagnostic accuracy of uncorrected images and uncorrected images plus gated.
Subject(s)
Coronary Artery Disease/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Adult , Aged , Aged, 80 and over , Exercise Test , Female , Humans , Male , Middle Aged , Sensitivity and Specificity , Tomography, X-Ray ComputedABSTRACT
The 2006 EANM Congress, held in Athens, Greece, was once again a major event in the nuclear medicine scientific and educational calendar. The scientific programme, which included the second biennial ISRTRD meeting, confirmed the major developments taking place in (1) the diagnostic and prognostic uses of nuclear medicine imaging (both in PET and in single-photon studies), (2) radionuclide therapies, (3) radiochemistry and radiopharmacy, and (4) physics. This paper outlines the major findings in each of these areas.
Subject(s)
Clinical Trials as Topic/trends , Diagnostic Imaging/trends , Nuclear Medicine/trends , Radiotherapy/trendsABSTRACT
OBJECTIVE: The inflammatory bowel disease (EII) has a chronic evolution with a frequent relapses. There is no specific diagnosis method to detect the patients with a high risk to relapse. The aim of the work was to analyse the prognostic value of 99mTc-HMPAO leukocyte scintigraphy (LS) performed during an acute attack of EII. MATERIAL AND METHODS: 18 patients (mean age 32 +/- 10 years) admitted for an acute attack of EII has been prospectively studied (5 ulcerative colitis [UC] and 13 Cronh's disease [CD]), excluding patient with prior steroids or immunosuppressive therapy during the last year. LS were obtained in basal conditions and following 3 weeks of steroid treatment and the scintigraphic activity index (SAI) has been calculated. Colonoscopy has been done in all patients, and CDAI in CD and Truelove index in UC have been calculated. Patients were followed up for 1 year. In the evolution the therapy requirements as well as the good response to initial treatment have been evaluated. RESULTS: All patients with UC and 4 patients with CD showed a SAI decrease > 50 % and all had a good clinical evolution. Only 2 out of the 9 patients with CD showing a IAG decrease < 50 % and had a good clinical evolution, the 7 remaining required additional medical treatment (immunosuppressors or surgery). CONCLUSION: LS may be of prognostic value in the management of EII. A SAI decrease > 50 % at 3 weeks of steroid treatment indicates a good clinical evolution.
Subject(s)
Inflammatory Bowel Diseases/diagnostic imaging , Leukocytes , Radiopharmaceuticals , Technetium Tc 99m Exametazime , Adult , Female , Humans , Male , Prognosis , Prospective Studies , Radionuclide ImagingABSTRACT
OBJECTIVE: The aim of the study was to evaluate the efficacy of lymphatic mapping and sentinel node biopsy in non-palpable breast cancer (NPBC) patients in comparison with palpable breast cancer (PBC) patients. MATERIAL AND METHODS: 199 breast cancer patients were studied. Patients were classified into two groups: NPBC and PBC. Following sentinel node biopsy all patients underwent axillary lymphadenectomy. Surgery was performed at 4-24 h after peritumoral injection of 111MBq 99mTc-nanocolloid. Histological sentinel node analysis was performed by cytological imprinting and delayed study. The following parameters were analyzed in both groups: scintigraphic and surgical detection rates, true positives (TP), true negatives (TN), sensitivity (S), predictive negative value (PNV), false negative rate (FNR) and global precision (GP) of the technique. RESULTS: No significant differences were observed (p > 0.05) in either the lymphoscintigraphy or surgical sentinel node detection, or drainage to internal mammary chain (p = 0.211) in both groups. Metastatic axillary prevalence was lower in NPBC group (p = 0.019). Similar S, NPV and GP values (>90 %) and FNR (< or = 6 %) were found in both groups. CONCLUSIONS: The reliability of the technique is similar in both groups. Drainage is predominantly axilar. Drainage to internal mammary chain was more frequently seen in medial tumours and in NPBC. Metastatic axillary prevalence was lower in the NPBC group.
Subject(s)
Breast Neoplasms/diagnostic imaging , Carcinoma/diagnostic imaging , Sentinel Lymph Node Biopsy , Adult , Aged , Axilla , Biomarkers, Tumor/analysis , Biopsy, Fine-Needle , Biopsy, Needle , Breast Neoplasms/chemistry , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma/chemistry , Carcinoma/pathology , False Negative Reactions , False Positive Reactions , Female , Humans , Lymph Node Excision , Lymphatic Metastasis , Mastectomy , Middle Aged , Palpation , Radionuclide Imaging , Radiopharmaceuticals , Sensitivity and Specificity , Technetium Tc 99m Aggregated AlbuminABSTRACT
OBJECTIVE: To evaluate the influence of tumour quadrant localization on the sentinel node (SN) detection and the visualisation of internal mammary chain (IM) drainage by radioisotopic techniques. 316 patients with breast cancer were studied. Mean age 57 years (range 29-88). All patients received 37-74 MBq of 99mTc-albumin nanocolloid in 2 ml by peritumoral injection. The breast cancer was located in the upper outer quadrant in 189 patients, in the upper inner in 57, in the lower outer in 57, in the lower inner in 55 and in the subareolar area in 18 patients. At two hours p.i., anterior and lateral chest lymphographies were obtained. The SN location was marked on the patient skin with permanent ink. SN was identified intraoperatively by the gamma probe. Histopatological analysis included imprints, delayed hematoxilin-eosin, inmunohistochemistry CAM 19-2 and PCR. RESULTS: The scintigraphy and surgical detection was in the upper outer quadrant of 90 % and 93 % respectively; in the lower outer quadrant of 91 % and 95 %, in the upper inner quadrant of 93 % and 95 %, in the lower inner quadrant 87 % and 95 % and in the subareolar area in 94 % and 83 %. The IM chain drainage was of 6 % in the UO, in the LO of 5 %, in the UI of 12 %, in the LI of 20 % and none in subareolar. CONCLUSIONS: Our data suggest that sentinel node location (quadrant) is not a influential factor in the scintigraphy and surgical detection. Tumours localised in internal quadrant show a higher rate of IM chain drainage.